Mantle cell lymphoma diagnosis

被引：1

作者：

Choukri, Mohammed ^{[1
]}

Taheri, Hafsa ^{[2
]}

Seddik, Rachid ^{[1
]}

Benkirane, Souad ^{[3
]}

Hamama, Afaf ^{[3
]}

Masrar, Azzelarab ^{[3
]}

Agoumi, Najia Benkirane ^{[3
]}

Chabraoui, Layachi ^{[4
]}

机构：

[1] Hop Al Farabi Oujda, Cent Lab, Rabat, Morocco

[2] Maternite Souissi, Serv Gynecol Obstet, Rabat, Morocco

[3] Hop Ibn Sina, Hematol Lab, Rabat, Morocco

[4] Hop Ibn Sina, Biochim Lab, Rabat, Morocco

来源：

ANNALES DE BIOLOGIE CLINIQUE | 2013年 / 71卷 / 01期

关键词：

mantle cell lymphoma; immunophenotyping; cytogenetics; SMALL LYMPHOCYTIC LYMPHOMA; CYCLIN D1; EXPRESSION; P53; PROLIFERATION; ATM; MCL; MYC; OVEREXPRESSION; DISTINCTION;

D O I：

10.1684/abc.2012.0782

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Recent classifications of non-Hodgkin's lymphomas based on combination of morphologic, immunophenotypic, and cytogenetic criteria have individualized mantle cell lymphoma (MCL). This clinico-biological entity which accounts for 3 to 10% of all non-Hodgkin's lymphomas, now appears to be a biological and therapeutic model for the understanding and treatment of hematologic malignancies. The present study consisting of two cases of MCL collated at laboratory of hematology of Rabat Ibn Sina hospital. The morphological appearance of MCL is characterized by diffuse or nodular lymph infiltration in the mantle zone, the osteo-medullary biopsy shows an interstitial infringement characterized by the presence of lymphocytes resembling centrocytes with cleaved and angular nuclei, dispersed chromatin, inconspicuous nucleoli and scanty cytoplasm. The flow cytometry showed immunophenotype positive for surface Ig, CD19, CD20, CD22, CD79b, CD5 and cyclin D1, and negative for CD10, CD23 and CD25. In conclusion, the methods of diagnosis and prognosis evaluation of mantle cell lymphoma are based on the nodular, medullary and blood morphology, the immunophenotypic, cytogenetic and molecular study of neoplastic cells.

引用

页码：107 / 112

页数：6

共 53 条

[1]

Aguilera NSI, 1998, HUM PATHOL, V29, P1134

[2]

Campo E, 1999, SEMIN HEMATOL, V36, P115

[3]

CARBONE PP, 1971, CANCER RES, V31, P1860

[4] Nuclei micro-array FISH, a desirable alternative for MCL diagnosis [J].

Chu, Hongjuan ;

Han, Xiqun ;

Jiang, Huiyong ;

Li, Feng ;

Li, Huiling ;

Zhao, Tong .

ANNALS OF HEMATOLOGY, 2011, 90 (11) :1299-1305

[5] Mantle cell lymphoma [J].

Cortelazzo, Sergio ;

Ponzoni, Maurilio ;

Ferreri, Andres J. M. ;

Dreyling, Martin .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (01) :78-101

[6]

Decaudin D, 2004, EMC HEMATOLOGIE, V1, P69

[7] Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade lymphoma Study Group [J].

Determann, Olaf ;

Hoster, Eva ;

Ott, German ;

Bernd, Heinz Wolfram ;

Loddenkemper, Christoph ;

Hansmann, Martin Leo ;

Barth, Thomas E. F. ;

Unterhalt, Michael ;

Hiddemann, Wolfgang ;

Dreyling, Martin ;

Klapper, Wolfram .

BLOOD, 2008, 111 (04) :2385-2387

[8]

DORFMAN DM, 1994, MODERN PATHOL, V7, P326

[9]

Dunphy CH, 1997, MODERN PATHOL, V10, P818

[10]

Felman P, 1997, ATLAS CYTOLOGIE GANG

← 1 2 3 4 5 6 →